Page last updated: 2024-08-26

bosentan anhydrous and Sjogren's Syndrome

bosentan anhydrous has been researched along with Sjogren's Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konishi, K; Kuriyama, T; Maruoka, M; Nakamura, M; Shigeta, A; Shinohara, M; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Toyama, S; Yasuda, T1
Guillevin, L1

Reviews

1 review(s) available for bosentan anhydrous and Sjogren's Syndrome

ArticleYear
Vasculopathy and pulmonary arterial hypertension.
    Rheumatology (Oxford, England), 2009, Volume: 48 Suppl 3

    Topics: Antihypertensive Agents; Bosentan; Churg-Strauss Syndrome; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Sulfonamides; Vasculitis

2009

Other Studies

1 other study(ies) available for bosentan anhydrous and Sjogren's Syndrome

ArticleYear
[Pulmonary hypertension in a patient on chronic hemodialysis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:1

    Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Sjogren's Syndrome; Sulfonamides

2009